EPIX - ESSAファ―マ (ESSA Pharma Inc.) ESSAファ―マ

 EPIXのチャート


 EPIXの企業情報

symbol EPIx
会社名 ESSA Pharma Inc (ESSAファ―マ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種    医療関連(Health Care)
概要 事業概要 --   ESSAファ―マはカナダのバイオ医薬品企業。主に臨床開発ステ―ジで、去勢抵抗性前立腺がんの治療に向けた小分子薬の開発を行う。同社はアンドロゲン受容体のアミノ末端領域を選択的にブロックする薬を開発し、既知のアンドロゲン受容体に依存する抵抗メカニズムを克服して前立腺がんの治療に当たる。本社はバンク―バ―。  ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer.
本社所在地 900 West Broadway Suite 720 Vancouver British Columbia V5Z 1K5 CAN
代表者氏名
代表者役職名
電話番号
設立年月日 39814
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 25人
url www.essapharma.com
nasdaq_url https://www.nasdaq.com/symbol/epix
adr_tso
EBITDA EBITDA ー
終値(lastsale) 3.25
時価総額(marketcap) 18772318.5
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 EPIXのテクニカル分析


 EPIXのニュース

   ESSA Pharma begins dosing of EPI-7386 in phase 1/2 prostate cancer study  2022/01/19 16:33:03 Seeking Alpha
ESSA Pharma (EPIX) said the first patient was dosed in a phase 1/2 study of its lead product candidate EPI-7386, in combination with Astellas Pharma''s (ALPMF) and Pfizer''s
   ESSA Pharma Announces First Patient Dosed In Phase 1/2 Clinical Trial Of EPI-7386 In Combination With Enzalutamide In Patients With Metastatic Castration-Resistant Prostate Cancer  2022/01/19 12:07:40 Benzinga
ESSA Pharma Inc. (NASDAQ: EPIX ) ("ESSA" or the "Company"), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced the first patient dosed in the Company-sponsored Phase 1/2 study to evaluate the safety, tolerability and preliminary efficacy of ESSA''s lead product candidate, EPI-7386, a first-in-class N-terminal domain androgen receptor inhibitor, in combination with Astellas Pharma Inc.''s ("Astellas") and Pfizer Inc.''s ligand-binding domain androgen receptor inhibitor, enzalutamide, in patients with metastatic castration-resistant prostate cancer ("mCRPC"). "The initiation of this combination trial with Astellas is a watershed moment for ESSA as we investigate the potential clinical benefit of inhibiting the androgen receptor through two independent pathways in the Full story available on Benzinga.com
   Essa Pharma Inc Shares Close the Week 25.9% Lower - Weekly Wrap  2022/01/16 03:44:08 Kwhen Finance
Essa Pharma Inc (EPIX) shares closed this week 25.9% lower than it did at the end of last week. The stock is currently down 34.4% year-to-date, down 41.1% over the past 12 months, and up 337.5% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Shares traded as high as $12.74 and as low as $8.27 this week.Shares closed 74.1% below its 52-week high and 25.6% above its 52-week low.Trading volume this week was 24.8% higher than the 10-day average and 126.6% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and beats it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and beats it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 5618.5% The company's stock price performance over the past 12 months lags the peer average by 155.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   ESSA Pharma (NASDAQ:EPIX) Stock Price Up 6.4%  2021/12/15 13:26:41 Dakota Financial News
Shares of ESSA Pharma Inc. (NASDAQ:EPIX) (TSE:EPI) rose 6.4% on Monday . The stock traded as high as $12.01 and last traded at $12.01. Approximately 3,086 shares changed hands during mid-day trading, a decline of 99% from the average daily volume of 373,471 shares. The stock had previously closed at $11.29. The firms 50 day []
   ESSA Pharma (NASDAQ:EPIX) Stock Price Up 6.4%  2021/12/15 13:26:41 Dakota Financial News
Shares of ESSA Pharma Inc. (NASDAQ:EPIX) (TSE:EPI) rose 6.4% on Monday . The stock traded as high as $12.01 and last traded at $12.01. Approximately 3,086 shares changed hands during mid-day trading, a decline of 99% from the average daily volume of 373,471 shares. The stock had previously closed at $11.29. The firms 50 day []
   Analysts Anticipate ESSA Pharma Inc. (NASDAQ:EPIX) to Announce -$0.25 EPS  2021/12/14 23:08:42 Dakota Financial News
Wall Street brokerages expect ESSA Pharma Inc. (NASDAQ:EPIX) (TSE:EPI) to announce earnings per share (EPS) of ($0.25) for the current quarter, Zacks reports. Zero analysts have provided estimates for ESSA Pharmas earnings, with the lowest EPS estimate coming in at ($0.31) and the highest estimate coming in at ($0.21). ESSA Pharma posted earnings of ($0.20) []
   Short Interest in ESSA Pharma Inc. (NASDAQ:EPIX) Decreases By 25.0%  2021/12/04 18:20:41 Transcript Daily
ESSA Pharma Inc. (NASDAQ:EPIX) (TSE:EPI) saw a significant drop in short interest in the month of November. As of November 15th, there was short interest totalling 937,100 shares, a drop of 25.0% from the October 31st total of 1,250,000 shares. Currently, 5.6% of the companys shares are short sold. Based on an average daily trading []
   ESSA Pharma Inc. (NASDAQ:EPIX) Sees Large Decrease in Short Interest  2021/12/03 16:56:41 Dakota Financial News
ESSA Pharma Inc. (NASDAQ:EPIX) (TSE:EPI) was the target of a large decrease in short interest in the month of November. As of November 15th, there was short interest totalling 937,100 shares, a decrease of 25.0% from the October 31st total of 1,250,000 shares. Currently, 5.6% of the shares of the company are short sold. Based []
   FY2022 EPS Estimates for ESSA Pharma Inc. Decreased by Jefferies Financial Group (NASDAQ:EPIX)  2021/12/01 06:30:41 Dakota Financial News
ESSA Pharma Inc. (NASDAQ:EPIX) (TSE:EPI) Investment analysts at Jefferies Financial Group dropped their FY2022 EPS estimates for shares of ESSA Pharma in a report released on Wednesday, November 24th. Jefferies Financial Group analyst M. Raycroft now forecasts that the company will post earnings per share of ($1.12) for the year, down from their previous []
   ESSA Pharma Inc Shares Approach 52-Week High - Market Mover  2021/03/12 22:30:00 Kwhen Finance
ESSA Pharma Inc shares closed today at 1.9% below its 52 week high of $32.69, giving the company a market cap of $1B. The stock is currently up 168.9% year-to-date, up 617.7% over the past 12 months, and up 846.3% over the past five years. This week, the Dow Jones Industrial Average rose 4.1%, and the S&P 500 rose 2.7%. Trading Activity Trading volume this week was 33.3% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   ESSA Pharma Inc Shares Close the Day 11.9% Lower - Daily Wrap  2021/02/16 22:30:00 Kwhen Finance
ESSA Pharma Inc shares closed today 11.9% lower than it did at the end of yesterday. The stock is currently up 108.8% year-to-date, up 365.6% over the past 12 months, and up 786.5% over the past five years. Today, the Dow Jones Industrial Average rose 0.2%, and the S&P 500 fell 0.1%. Trading Activity Shares traded as high as $32.69 and as low as $18.53 this week.Shares closed 2e+1% below its 52-week high and 7e+2% above its 52-week low.Trading volume this week was 25.1% lower than the 10-day average and 33.7% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price lags the S&P 500 Index today, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, beats it on a 1-year basis, and beats it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector today, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   ESSA Pharma Inc Shares Close the Week 59.8% Higher - Weekly Wrap  2021/02/12 22:30:00 Kwhen Finance
ESSA Pharma Inc shares closed this week 59.8% higher than it did at the end of last week. The stock is currently up 137.0% year-to-date, up 428.9% over the past 12 months, and up 878.5% over the past five years. This week, the Dow Jones Industrial Average rose 1.1%, and the S&P 500 rose 1.3%. Trading Activity Shares traded as high as $32.69 and as low as $17.70 this week.Shares closed 1e+1% below its 52-week high and 8e+2% above its 52-week low.Trading volume this week was 318.8% higher than the 10-day average and 507.0% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold.The stock closed at 24.0% higher than its 5-day moving average, 49.7% higher than its 20-day moving average, and 174.3% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   ESSA Pharma Inc Shares Close the Day 10.1% Lower - Daily Wrap  2021/01/27 22:30:00 Kwhen Finance
ESSA Pharma Inc shares closed today 10.1% lower than it did at the end of yesterday. The stock is currently up 38.3% year-to-date, up 187.0% over the past 12 months, and up 407.7% over the past five years. Today, the Dow Jones Industrial Average fell 2.1%, and the S&P 500 rose 0.1%. Trading Activity Shares traded as high as $20.19 and as low as $16.09 this week.Shares closed 1e+1% below its 52-week high and 4e+2% above its 52-week low.Trading volume this week was 34.4% lower than the 10-day average and 32.8% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price lags the S&P 500 Index today, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, beats it on a 1-year basis, and beats it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector today, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   ESSA Pharma Inc Shares Close in on 52-Week High - Market Mover  2021/01/22 22:30:00 Kwhen Finance
ESSA Pharma Inc shares closed today at 0.2% below its 52 week high of $18.23, giving the company a market cap of $583M. The stock is currently up 52.6% year-to-date, up 222.7% over the past 12 months, and up 424.5% over the past five years. This week, the Dow Jones Industrial Average rose 0.6%, and the S&P 500 rose 1.9%. Trading Activity Trading volume this week was 39.1% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

 関連キーワード  (― 米国株 ESSAファ―マ EPIX ESSA Pharma Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)